cbdMD Inc. (YCBD): Price and Financial Metrics


cbdMD Inc. (YCBD): $0.32

0.05 (+17.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

YCBD Stock Summary

  • YCBD has a higher market value than only 4.8% of US stocks; more precisely, its current market capitalization is $13,503,898.
  • YCBD's price/sales ratio is 0.27; that's higher than the P/S ratio of merely 7.74% of US stocks.
  • In terms of volatility of its share price, YCBD is more volatile than 92.28% of stocks we're observing.
  • Stocks that are quantitatively similar to YCBD, based on their financial statements, market capitalization, and price volatility, are GNLN, WYY, FWRD, DWSN, and NATR.
  • YCBD's SEC filings can be seen here. And to visit CBDMD INC's official web site, go to www.cbdmd.com.

YCBD Valuation Summary

  • YCBD's price/sales ratio is 0.3; this is 85% lower than that of the median Healthcare stock.
  • Over the past 60 months, YCBD's EV/EBIT ratio has gone up 26.4.

Below are key valuation metrics over time for YCBD.

Stock Date P/S P/B P/E EV/EBIT
YCBD 2022-11-25 0.3 0.3 -0.2 -0.1
YCBD 2022-11-23 0.3 0.3 -0.2 -0.1
YCBD 2022-11-22 0.3 0.3 -0.2 -0.1
YCBD 2022-11-21 0.3 0.3 -0.2 -0.1
YCBD 2022-11-18 0.3 0.3 -0.2 -0.1
YCBD 2022-11-17 0.3 0.3 -0.2 -0.2

YCBD Growth Metrics

    Its 2 year cash and equivalents growth rate is now at -10.27%.
  • The 5 year net income to common stockholders growth rate now stands at 739.55%.
  • Its 5 year net cashflow from operations growth rate is now at -761.1%.
Over the past 15 months, YCBD's revenue has gone up $3,201,854.

The table below shows YCBD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 49.66523 -17.37563 -72.30952
2022-03-31 51.63286 -19.61295 -38.69787
2021-12-31 53.80259 -17.36987 -46.1109
2021-09-30 56.80907 -14.09343 -35.44517
2021-06-30 46.38735 -10.14653 -27.94803
2021-03-31 46.46338 -6.668303 -37.97779

YCBD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • YCBD has a Quality Grade of D, ranking ahead of 8.65% of graded US stocks.
  • YCBD's asset turnover comes in at 0.394 -- ranking 43rd of 50 Consumer Goods stocks.
  • 500 - Internal server error

The table below shows YCBD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.394 0.660 -1.263
2021-03-31 0.398 0.652 -1.673
2020-12-31 0.384 0.654 -0.407
2020-09-30 0.384 0.630 0.483
2020-06-30 0.370 0.647 1.350
2020-03-31 0.354 0.643 0.476

YCBD Stock Price Chart Interactive Chart >

Price chart for YCBD

YCBD Price/Volume Stats

Current price $0.32 52-week high $1.57
Prev. close $0.28 52-week low $0.20
Day low $0.28 Volume 858,100
Day high $0.32 Avg. volume 269,306
50-day MA $0.27 Dividend yield N/A
200-day MA $0.52 Market Cap 19.61M

cbdMD Inc. (YCBD) Company Bio


cbdMD, Inc. is a nationally recognized consumer cannabidiol brand which engages in producing and distributing of CBD products. Its products include CBD tinctures, CBD gummies, CBD topical, CBD bath bombs, and CBD pet products. cbdMD was founded by Caryn Dunayer in March 2015 and is headquartered in Charlotte, NC.


YCBD Latest News Stream


Event/Time News Detail
Loading, please wait...

YCBD Latest Social Stream


Loading social stream, please wait...

View Full YCBD Social Stream

Latest YCBD News From Around the Web

Below are the latest news stories about CBDMD INC that investors may wish to consider to help them evaluate YCBD as an investment opportunity.

cbdMD Successfully Launches Into a Growing Japanese Market

Charlotte, North Carolina--(Newsfile Corp. - November 29, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized health and wellness companies, has announced it has completed a successful initial launch into the emerging Japanese market. According to Brightfield Group, a leading CBD research firm, Japan is the largest CBD market by revenue in the Asia Pacific and Middle East region. cbdMD believes ...

Yahoo | November 29, 2022

cbdMD'S Human Clinical Study Demonstrates Strong Pain Benefits

Initial Results from the First of Its Kind Clinical Study Demonstrate cbdMD's Proprietary Broad Spectrum Hemp Extract Reduces Pain in Healthy Adults. Charlotte, North Carolina--(Newsfile Corp. - November 17, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the first results from its recently concluded human clinical trial conducted at the University of South Carolina. These studies

Yahoo | November 17, 2022

cbdMD to Present at ThinkEquity Conference on October 26, 2022, in New York City

Charlotte, North Carolina--(Newsfile Corp. - October 25, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted, and widely recognized CBD companies, announced today that the Company will present at the ThinkEquity Conference on Wednesday, October 26, 2022, at 12:30pm ET at the Mandarin Oriental Hotel in New York City. cbdMD's President Kevin MacDermott and Chief Financial Officer Ronan Kennedy will be conducting one-on-one meetings through

Yahoo | October 25, 2022

cbdMD Launches Powerful New Product Designed to Reduce Pain - cbdMD MAX

Formulated with Proprietary Cannabinoid Blend and Clinically Proven Ingredient to Address Pain Charlotte, North Carolina--(Newsfile Corp. - October 18, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced their latest product launch geared toward the over 50 million Americans who suffer from some form of everyday pain or discomfort. cbdMD MAX features their innovative formula that combines cb

Yahoo | October 18, 2022

cbdMD Announces Strategic Launch of Strongest CBD at the Best Value

High Strength Product Designed to Make People Feel Their Best. Charlotte, North Carolina--(Newsfile Corp. - October 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced their latest initiative that involves a new line up of products delivering higher concentrations of CBD for daily use. According to category insights, people need to take enough CBD so they can feel better and ...

Yahoo | October 13, 2022

Read More 'YCBD' Stories Here

YCBD Price Returns

1-mo 0.09%
3-mo -12.47%
6-mo -34.71%
1-year -76.98%
3-year -89.12%
5-year -93.47%
YTD -70.37%
2021 -63.39%
2020 30.53%
2019 -26.86%
2018 -28.97%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7982 seconds.